Interv Akut Kardiol. 2002;1(2):63

Akutní koronární syndrom: některé aspekty moderní farmakoterapie a revaskularizace

Petr Kala

Published: December 31, 2002  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kala P. Akutní koronární syndrom: některé aspekty moderní farmakoterapie a revaskularizace. Interv Akut Kardiol. 2002;1(2):63.
Download citation

References

  1. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators (CURE). Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Errata, N Eng J Med 2001;345:1506, 1716). Go to original source... Go to PubMed...
  2. Mehta SR, Yusuf S, Peters RJ et al. for the Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-533. Go to original source... Go to PubMed...
  3. CREDO. Kongres AHA 2002.
  4. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961. Go to original source... Go to PubMed...
  5. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-1696. Go to original source... Go to PubMed...
  6. Lincoff AM, LeRoy A, LeNarz A et al. Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Ann Thorac Surg 2000;70: 516-520. Go to original source... Go to PubMed...
  7. Lemmer JH. Clinical experience in coronary bypass surgery for abciximab-treated patients. Ann Thorac Surg 2000;70:S33-37. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.